In this cohort of NPC tumors, 66.7 and 70.7% of tumors demonstrated increased FGF1 [transcripts per million (TPM) > 10.5] and FGF2 (tpm > 19.5) gene expression, respectively, when considering the highest threshold observed in normal samples. The gene discussed is FGF2; the disease is nasopharyngeal carcinoma.